Corneal staining reductions observed after treatment with systane® lubricant eye drops

Advances in Therapy

Volumn 25, Issue 11, 2008, Pages 1191-1199

  Christensen, Mike T ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

Dry eye; Inflammation; Ocular staining; Ocular surface; Systane

Indexed keywords

EYE DROPS; MACROGOL DERIVATIVE; PROPYLENE GLYCOL;

ARTICLE; CORNEA; DRUG COMBINATION; DRUG EFFECT; DRY EYE; HUMAN; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; VISUAL SYSTEM EXAMINATION;

CORNEA; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRUG COMBINATIONS; DRY EYE SYNDROMES; HUMANS; OPHTHALMIC SOLUTIONS; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77449103388     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-008-0112-0     Document Type: Article

References (25)

1. DEWS. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:93-107.
2. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-1268.
3. Muñoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825. (Pubitemid 30395181)
4. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326. (Pubitemid 36904081)
5. Schein OD, Hochberg MC, Muñoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med. 1999;159:1359-1363. (Pubitemid 29293598)
6. Schein OD, Muñoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124:723-728. (Pubitemid 27523148)
7. Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol. 2004;15:299-304. (Pubitemid 38962108)
8. Foulks GN. What is dry eye and what does it mean to the contact lens wearer? Eye Contact Lens. 2003;29(1 Suppl.):S96-100; discussion S115-S118, S192-S194.
9. Giford P, Evans BJ, Morris J. A clinical evaluation of Systane. Contact Lens Anterior Eye. 2006;29:31-40. (Pubitemid 43372726)
10. DEWS. The defnition and classifcation of dry eye disease: report of the Defnition and Classifcation Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:75-92.
11. Lemp MA. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221-232.
12. DEWS. Management and therapy of dry eye disease: report of the Management and Terapy Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:163-178.
13. Christensen MT, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 2004;28:55-62. (Pubitemid 38161174)
14. D'Aienzo P, Ousler GW, Schindelar MR. A comparison of two marketed artifcial tears in improvement of tear flm stability as measured by tear flm break-up time (TFBUT) and ocular protection and ocular protection index (OPI). Poster presented at: Tear Film and Ocular Surface Society Meeting; September 5-8, 2007; Taorima, Sicily.
15. Ousler GW, Michaelson C, Christensen MT. An evaluation of tear flm breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Cornea. 2007;26:949-952. (Pubitemid 47329799)
16. Sall KN, Cohen SM, Christensen MT, Stein JM. An evaluation of the efcacy of a cyclosporine-based dry eye therapy when used with marketed artifcial tears as supportive therapy in dry eye. Eye Contact Lens. 2006;32:21-26. (Pubitemid 43189090)
17. Christensen MT, Cohen S, Tudor M. Confrmation of efcacy by cessation of therapy with Systane lubricant eye drops. Poster presented at: American Academy of Ophthalmology annual meeting; October 15-18, 2005; Chicago, Illinois.
18. DEWS. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:108-152.
19. DEWS. Design and conduct of clinical trials: report of the Clinical Trials Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:153-162.
20. Hamano T. Dry eye treatment with eye drops that stimulate mucin production. Adv Exp Med Biol. 1998;438:965-968. (Pubitemid 28303847)
21. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efcacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639. (Pubitemid 30191329)
22. Tauber J, Davitt WF, Bokosky JE, et al. Double-masked, placebo-controlled safety and efcacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Cornea. 2004;23:784-792. (Pubitemid 39447308)
23. ™: information for practitioners. Allergan web site. Available at: www. allergan.com. Accessed November 12, 2007.
24. Hardten DR, Brown MJ, Pham-Vang S. Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease. Curr Med Res Opin. 2007;23:2083-2091. (Pubitemid 350252898)
25. Osmoprotection-a novel approach to artifcial tear technology. Review of optometry teleconferences. Review of Optometry: Newtown Square, PA. Presented variously from February 26 through April 2, 2007.